Integrin Inhibitors in Inflammatory Bowel Disease: From Therapeutic Antibodies to Small-Molecule Drugs

Affiliations

Editorial

Julian Panés. Gastroenterology. 2021 Dec.

. 2021 Dec;161(6):1791-1793.

doi: 10.1053/j.gastro.2021.09.016. Epub 2021 Sep 14.

¹ Inflammatory Bowel Disease Unit, Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain. Electronic address: jpanes@clinic.cat.

No abstract available

Comment on

PTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis.
Sandborn WJ, Mattheakis LC, Modi NB, Pugatch D, Bressler B, Lee S, Bhandari R, Kanwar B, Shames R, D'Haens G, Schreiber S, Danese S, Feagan B, Pai RK, Liu DY, Gupta S. Sandborn WJ, et al. Gastroenterology. 2021 Dec;161(6):1853-1864.e10. doi: 10.1053/j.gastro.2021.08.045. Epub 2021 Aug 30. Gastroenterology. 2021. PMID: 34474038 Clinical Trial.